Prior reports have shown that miR-34a is downregulated in GBM compared to normal brain, and that it inhibits cell proliferation, survival, and invasion in adherent glioma cell lines by targeting MET, NOTCH1, NOTCH2, and CDK6 [10]. Here, MET is linked to glioblastoma.